These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35311705)

  • 41. Source estimation of spontaneous MEG oscillations in mild cognitive impairment.
    Osipova D; Rantanen K; Ahveninen J; Ylikoski R; Häppölä O; Strandberg T; Pekkonen E
    Neurosci Lett; 2006 Sep; 405(1-2):57-61. PubMed ID: 16854528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spontaneous oscillatory markers of cognitive status in two forms of dementia.
    Shah-Basak PP; Kielar A; Deschamps T; Verhoeff NP; Jokel R; Meltzer J
    Hum Brain Mapp; 2019 Apr; 40(5):1594-1607. PubMed ID: 30421472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropsychological and neurophysiological characterization of mild cognitive impairment and Alzheimer's disease in Down syndrome.
    García-Alba J; Ramírez-Toraño F; Esteba-Castillo S; Bruña R; Moldenhauer F; Novell R; Romero-Medina V; Maestú F; Fernández A
    Neurobiol Aging; 2019 Dec; 84():70-79. PubMed ID: 31518951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Classification of Alzheimer's disease based on hippocampal multivariate morphometry statistics.
    Zheng W; Liu H; Li Z; Li K; Wang Y; Hu B; Dong Q; Wang Z
    CNS Neurosci Ther; 2023 Sep; 29(9):2457-2468. PubMed ID: 37002795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced visual event-related δ oscillatory responses in amnestic mild cognitive impairment.
    Yener GG; Kurt P; Emek-Savaş DD; Güntekin B; Başar E
    J Alzheimers Dis; 2013; 37(4):759-67. PubMed ID: 23948923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2014 Aug; 35(8):3701-25. PubMed ID: 24443091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discriminating Alzheimer's disease progression using a new hippocampal marker from T1-weighted MRI: The local surface roughness.
    Platero C; López ME; Carmen Tobar MD; Yus M; Maestu F
    Hum Brain Mapp; 2019 Apr; 40(5):1666-1676. PubMed ID: 30451343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease.
    Giacomucci G; Galdo G; Polito C; Berti V; Padiglioni S; Mazzeo S; Chiaro E; De Cristofaro MT; Bagnoli S; Nacmias B; Sorbi S; Bessi V
    Behav Brain Res; 2022 Jun; 428():113893. PubMed ID: 35429513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oscillatory characteristics of resting-state magnetoencephalography reflect pathological and symptomatic conditions of cognitive impairment.
    Hoshi H; Hirata Y; Fukasawa K; Kobayashi M; Shigihara Y
    Front Aging Neurosci; 2024; 16():1273738. PubMed ID: 38352236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields.
    Kim GW; Kim BC; Park KS; Jeong GW
    Sci Rep; 2020 Jul; 10(1):10912. PubMed ID: 32616841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study.
    Ong KT; Villemagne VL; Bahar-Fuchs A; Lamb F; Langdon N; Catafau AM; Stephens AW; Seibyl J; Dinkelborg LM; Reininger CB; Putz B; Rohde B; Masters CL; Rowe CC
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):431-6. PubMed ID: 24970906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of spontaneous MEG activity in mild cognitive impairment and Alzheimer's disease using spectral entropies and statistical complexity measures.
    Bruña R; Poza J; Gómez C; García M; Fernández A; Hornero R
    J Neural Eng; 2012 Jun; 9(3):036007. PubMed ID: 22571870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.
    Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
    Alzheimers Res Ther; 2020 Jul; 12(1):82. PubMed ID: 32641111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant resting-state oscillatory brain activity in Parkinson's disease patients with visual hallucinations: An MEG source-space study.
    Dauwan M; Hoff JI; Vriens EM; Hillebrand A; Stam CJ; Sommer IE
    Neuroimage Clin; 2019; 22():101752. PubMed ID: 30897434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Poza J; Gómez C; García M; Tola-Arribas MA; Carreres A; Cano M; Hornero R
    Curr Alzheimer Res; 2017; 14(9):924-936. PubMed ID: 28290246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural and Functional Abnormalities of Olfactory-Related Regions in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen B; Wang Q; Zhong X; Mai N; Zhang M; Zhou H; Haehner A; Chen X; Wu Z; Auber LA; Rao D; Liu W; Zheng J; Lin L; Li N; Chen S; Chen B; Hummel T; Ning Y
    Int J Neuropsychopharmacol; 2022 May; 25(5):361-374. PubMed ID: 34893841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
    Noguchi-Shinohara M; Koike M; Morise H; Kudo K; Tsuchimine S; Komatsu J; Abe C; Kitagawa S; Ikeda Y; Yamada M
    PLoS One; 2021; 16(11):e0259677. PubMed ID: 34739526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.